Get started
BeyondSpring, Inc.BeyondSpring, Inc.BeyondSpring, Inc.

BeyondSpring, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals

BYSI trade ideas

BYSI Harmonics: Swing trade!If the shark pattern completes a bounce at 1.13, instead of 0.886, I will consider this a low risk swing into 0.382 and 0.618 retracements. Usually, one would trade this straight into a 0.5 retracement. I am not sure about the other larger possible pattern here. It's still just an idea; however, considering the recent price targets of $50 and $100, as well as, the pdufa scheduled for Oct. 30th, there is potential for this final pattern to be realized. Good luck, trade safely, and let's make that money!
NASDAQ:BYSILong
by Antikythera_Mechanism
2
Sunday Prep 8/08 - $BYSI Setting up perfectly for a SQUEEZE!!This name is set up perfectly for a squeeze. it gapped up big Wednesday morning after reporting positive top-line data in late-stage study of lung cancer combo drug. it inevitably pulled in tons of shorts due to its large gap but the stock held relatively well and even pushed up later in the day. the problem is that shorts see that they will most likely raise through a secondary and they get extremely bearish on the stock which in turn makes them hold and become stubborn. but this company will more than likely price the secondary rather strong and shorts will not get bailed out like they’re hoping they will. Friday the price action was really constructive. this coming week I will definitely be watching for any type of weakness that actually ends up trapping more shorts. I will possibly trade this intraday but the real thing I’m interested in is to watch for when they actually announce the secondary to see if there’s a flush to scoop. But I don’t necessarily want to be holding this thing long into the secondary. I would prefer to be flat at that point and then react.
NASDAQ:BYSILong
by TrueTraderOfficial
BYSI BeyondSpring Price TargetBYSI BeyondSpring drug, plinabulin, increased overall survival and improved other measures of disease while staving off a dangerous side effect associated with Chemotherapy. BeyondSpring is preparing to ask for plinabulin approval in the U.S. and China. On 8/4/2021 J. Pantginis from HC Wainwright brokerage Upgraded BYSI BeyondSpring from Neutral to Buy giving a Price Target of $100.00 My price target is the all time high resistance of 48usd until we hear some news from the FDA.
NASDAQ:BYSILong
by TopgOptions
2
BYSI Technical Analysis 🧙BeyondSpring Inc is engaged in clinical stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. The Company has created Plinabulin which is marine derived small-molecule with a number of distinct biological activities that may provide multiple therapeutic opportunities. Plinabulin has increased the survival of neutrophils, a type of white blood cell important in the prevention of bacterial infections. The Company has a scalable business model integrating clinical resources in the United States and China. If you want more trading ideas like this one ,🎯 press a thumb up! 👍 Have a question? Don't be shy to ask! 🤓 Interested to study how to analyze charts, follow me!
NASDAQ:BYSILong
by unfair_advantage